LONDON, Sept. 10, 2025 /PRNewswire/ — Elliott Investment Management L.P. and Elliott Advisors (UK) Limited (“Elliott”), which advise funds that together have a significant ownership stake in The Kansai Electric Power Company, Inc. (“Kansai Electric” or the “Company”), making Elliott one of the Company’s largest shareholders, today issued the following statement:
Elliott’s investment in Kansai Electric reflects our respect for the Company’s history and its importance to the Kansai region, as well as our belief in its potential as it continues to build on its position as Japan’s leading producer of low-cost and low-carbon electricity. We look forward to continuing to work constructively with Kansai Electric’s management team and other key stakeholders to strengthen the Company’s core business. By increasing shareholder returns, unlocking capital from its non-core assets and improving profitability, we believe the Company can enhance its funding flexibility for future growth and bolster its appeal as a long-term investment proposition.
About Elliott
Elliott Investment Management L.P. (together with its affiliates, “Elliott”) manages approximately $76.1 billion of assets as of June 30, 2025. Founded in 1977, it is one of the oldest funds under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm. Elliott Advisors (UK) Limited is an affiliate of Elliott Investment Management L.P.
Media Contacts:
London
Alice Best
Elliott Advisors (UK) Limited
T: +44 203 009 1715
abest@elliottadvisors.co.uk
Tokyo
Brett Wallbutton
Ashton Consulting
T: +81 (0) 3 5425-7220
b.wallbutton@ashton.jp
Logo – https://mma.prnewswire.com/media/1179754/5504262/Elliot_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/elliott-statement-on-the-kansai-electric-power-company-inc-302553091.html
NEURODYNE DROPS INTRODUCED AS A COGNITIVE WELLNESS SUPPLEMENT SUPPORTING HEALTHY MEMORY, FOCUS, AND MENTAL CLARITY…
New York City, NY, Jan. 17, 2026 (GLOBE NEWSWIRE) -- OPTIVELL INTRODUCED AS A NEW…
SUGAR CLEAN DROPS ANNOUNCED AS A NEW SUPPLEMENT SUPPORTING HEALTHY BLOOD SUGAR AND METABOLIC WELLNESS…
New York City, NY, Jan. 17, 2026 (GLOBE NEWSWIRE) -- The 2026 Reality: People Aren’t…
Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the…
January 16, 2026 16:15 ET | Source: Zenas BioPharma WALTHAM, Mass., Jan. 16, 2026 (GLOBE…